And when it hints at something (like assisted suicide a few years ago) you know where their editorial page will end up.
Of course they don't use the term "death panel", but read between the lines.
Extremely Expensive Cancer Drugs
The Wall Street Journal took an opposite view towards Avastin for women with breast cancer, saying it should be between the patient and her physicians.
WSJ editorial about Avastin: "The Race Against the Cure"
Comments